Stockreport

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors [Yahoo! Finance]

Sagimet Biosciences Inc.  (SGMT) 
PDF developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the appointments of two biotechn [Read more]